Back to Bank of New York Mellon Corp Bank of New York Mellon Corp

ANTXANTX
Showing 1 of 5 quarters

Position history for Bank of New York Mellon CorpBank of New York Mellon Corp's holdings in AN2 THERAPEUTICS INC

Bank of New York Mellon Corp holds 67,676 shares of ANTX (AN2 THERAPEUTICS INC), worth $327,552 as of 2026-Q2. This is a new position. ANTX represents 0.0% of Bank of New York Mellon Corp's portfolio.

Current Value

$327,552

Current Shares

67,676

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
67,676
-
$327,5520.0%$4.84
33

Other major holders of ANTX: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used